By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dicerna Pharmaceuticals 

480 Arsenal Street
Building 1, Suite 120
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-621-8097 Fax: n/a


Start Up

Company News
Sparring Over Trade Secrets, Dicerna (DRNA) Brings New Antitrust Suit Against Alnylam (ALNY) 8/11/2017 8:09:27 AM
Dicerna (DRNA) Reports Second Quarter 2017 Financial And Operating Results And Provides Corporate Update 8/11/2017 6:40:09 AM
Dicerna (DRNA) To Report Second Quarter 2017 Financial Results And Host Conference Call On August 10, 2017 8/3/2017 7:04:20 AM
Dicerna (DRNA) Expands Lead Galxc Development Program To Encompass All Forms Of Primary Hyperoxaluria (PH) And Reveals New Therapeutic Target For DCR-PHXC 7/17/2017 6:16:27 AM
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) 6/15/2017 6:30:17 AM
Dicerna (DRNA) Announces Appointment Of Ralf Rosskamp, M.D., As Chief Medical Officer 6/8/2017 6:42:43 AM
Dicerna (DRNA) Reports First Quarter 2017 Financial And Operational Results And Provides Corporate Update 5/9/2017 6:44:05 AM
Dicerna (DRNA) To Report First Quarter 2017 Financial Results And Host Conference Call On May 8, 2017 5/2/2017 6:30:56 AM
Dicerna (DRNA) Announces Closing Of $70 Million Convertible Preferred Stock Financing 4/12/2017 6:14:53 AM
Dicerna (DRNA) Secures $70 Million In Convertible Preferred Stock Financing 3/31/2017 7:02:02 AM